Sign in

CIK 0001035354

  • Non-accelerated filer
  • Smaller reporting company

Eloxx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841368850
Phone
+1 781-577-5300
Business address
P.O. BOX 274, ARLINGTON, MA, 02476
Former names
Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-12-20 WEAVER GREGORY L Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +399,266 399,266
2017-12-20 WEAVER GREGORY L Chief Financial Officer Grant or award · Stock Option (Right to Buy) +399,266 399,266
2017-12-19 Opko Health, Inc. 10% owner Grant or award +495,126 1,289,818
2017-12-19 RECTOR DAVID See Remarks Grant or award · Common Stock Option (Right to Buy) +27,500 27,500
2017-12-19 BRACA JOHN N See Remarks Grant or award · Company Stock Option +18,190 18,190
2017-12-19 FROST PHILLIP MD ET AL See Remarks Grant or award · Company Stock Option +3,621 3,621
2017-12-19 Rubin Steven D Director Grant or award · Common Stock Option (Right to Buy) +43,189 43,189
2017-09-19 Opko Health, Inc. 10% owner Conversion +1,250,006 15,893,844
2017-09-19 Opko Health, Inc. 10% owner Conversion · 0% Series C Convertible Perferred −66,667 0
2017-08-10 Opko Health, Inc. 10% owner Conversion +1,563,123 $0.10 $156K 12,080,139
2017-08-10 Opko Health, Inc. 10% owner Conversion +2,563,699 $0.10 $256K 14,643,838
2017-08-10 Opko Health, Inc. 10% owner Conversion · Convertible Promissory Note −0 0
2017-08-10 Opko Health, Inc. 10% owner Conversion · Convertible Promissory Note −0 0
2017-02-14 Rubin Steven D Director Grant or award · Company Stock Option +160,227 $0.11 $18K 160,227
2017-02-14 FROST PHILLIP MD ET AL Director Grant or award · Company Stock Option +109,091 $0.11 $12K 109,091
2017-02-14 BRACA JOHN N Director Grant or award · Company Stock Option +167,045 $0.11 $18K 167,045
2016-06-13 Rubin Steven D Director Grant or award · Company Stock Option +89,773 $0.11 $10K 89,773
2016-06-13 FROST PHILLIP MD ET AL Director Grant or award · Company Stock Option +78,409 $0.11 $9K 78,409
2016-06-13 BRACA JOHN N Director Grant or award · Company Stock Option +89,773 $0.11 $10K 89,773
2015-11-19 Rubin Steven D Director Grant or award · Company Stock Option +40,000 $0.25 $10K 40,000

Page 17 of 20 · 388 trades